Literature DB >> 31606623

Hsa_circ_0070269 inhibits hepatocellular carcinoma progression through modulating miR-182/NPTX1 axis.

Xiaotong Su1, Jutong Su2, Hua He3, Yong Zhan3, Haichao Liu3.   

Abstract

Circular RNAs (circRNAs) have recently been shown to play critical roles in tumorigenesis. However, the roles of circRNAs in hepatocellular carcinoma (HCC) remain largely unknown. In the present study, we identified a novel circRNA (hsa_circ_0070269) was significantly decreased in HCC tissues and cell lines, low hsa_circ_0070269 expression was positively associated with advanced tumor stage, lymph node metastasis, and poor overall survival. Hsa_circ_0070269 overexpression suppressed proliferation and invasion of HCC cells in vitro and reduced tumor growth in vivo. Mechanistically, hsa_circ_0070269 increased NPTX1 expression via sponging miR-182 in HCC cells, which inhibited aggressive tumor behavior. Taken together, our findings suggest that hsa_circ_0070269 might play an important role in HCC development via miR-182/NPTX1 axis, therefore could serve as a potential therapeutic target for HCC treatment.
Copyright © 2019. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Hepatocellular carcinoma; NPTX1; circRNAs; hsa_circ_0070269; miR-182

Mesh:

Substances:

Year:  2019        PMID: 31606623     DOI: 10.1016/j.biopha.2019.109497

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  11 in total

1.  Hsa_circ_0065217 promotes growth and metastasis of renal cancer through regulating the miR-214-3p-ALPK2 axis.

Authors:  Jia-Sheng Yan; Qi Chen; Ya-Lin Li; Yun-Qiu Gao
Journal:  Cell Cycle       Date:  2021-10-27       Impact factor: 5.173

2.  circRAE1 promotes colorectal cancer cell migration and invasion by modulating miR-338-3p/TYRO3 axis.

Authors:  Jianhua Xu; Jiabin Du; Junxing Chen; Weinan Liu; Pengcheng Wang; Kai Ye
Journal:  Cancer Cell Int       Date:  2020-09-03       Impact factor: 5.722

3.  The Hsa_circ_0091579/miR-940/TACR1 Axis Regulates the Development of Hepatocellular Carcinoma.

Authors:  Peiqiang Jiang; Wei Han; Yu Fu; Qingmin Chen
Journal:  Cancer Manag Res       Date:  2020-09-28       Impact factor: 3.989

4.  CircRNA-006258 Sponge-Adsorbs miR-574-5p to Regulate Cell Growth and Milk Synthesis via EVI5L in Goat Mammary Epithelial Cells.

Authors:  Meng Zhang; Li Ma; Yuhan Liu; Yonglong He; Guang Li; Xiaopeng An; Binyun Cao
Journal:  Genes (Basel)       Date:  2020-06-28       Impact factor: 4.096

5.  [Expression and Diagnostic Value of NPTX1 in Thymoma Patients].

Authors:  Xin Du; Lei Yu; Ling Yang; Dingfang Cao; Ying Zhang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-01-20

6.  Circular RNA hsa_circ_0003141 promotes tumorigenesis of hepatocellular carcinoma via a miR-1827/UBAP2 axis.

Authors:  Yong Wang; Rongfen Gao; Jinpeng Li; Shaotao Tang; Shuai Li; Qiangsong Tong; Yongzhong Mao
Journal:  Aging (Albany NY)       Date:  2020-05-28       Impact factor: 5.682

7.  Hsa_circ_RNA_0011780 Represses the Proliferation and Metastasis of Non-Small Cell Lung Cancer by Decreasing FBXW7 via Targeting miR-544a.

Authors:  Yong Liu; Chuanping Yang; Chengsong Cao; Qing Li; Xin Jin; Hanping Shi
Journal:  Onco Targets Ther       Date:  2020-01-23       Impact factor: 4.147

Review 8.  Circular RNAs: Emerging Role in Cancer Diagnostics and Therapeutics.

Authors:  Anuva Rajappa; Sucharita Banerjee; Vivek Sharma; Piyush Khandelia
Journal:  Front Mol Biosci       Date:  2020-10-28

9.  circRNA 001306 enhances hepatocellular carcinoma growth by up-regulating CDK16 expression via sponging miR-584-5p.

Authors:  Qian Liu; Cixiao Wang; Zeyou Jiang; Shan Li; Fang Li; Hua-Bing Tan; Su-Yang Yue
Journal:  J Cell Mol Med       Date:  2020-11-01       Impact factor: 5.295

10.  Hsa_circ_0006916 Knockdown Represses the Development of Hepatocellular Carcinoma via Modulating miR-599/SRSF2 Axis.

Authors:  Zhixiang Zhu; Songhe Shen; Sen Zhao; Zhixue Wang
Journal:  Onco Targets Ther       Date:  2020-11-04       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.